APA (7th ed.) Citation

CI, L., YW, C., MS, Y., YW, W., YH, W., & YH, C. (2026). Liver-directed AAV-IL-10 therapy enhances CD8+ T cell-mediated immunity against hepatocellular carcinoma. Journal for immunotherapy of cancer, 14(3), . https://doi.org/10.1136/jitc-2025-012460

Chicago Style (17th ed.) Citation

CI, Lin, Chiu YW, Yen MS, Wang YW, Wu YH, and Chuang YH. "Liver-directed AAV-IL-10 Therapy Enhances CD8+ T Cell-mediated Immunity Against Hepatocellular Carcinoma." Journal for Immunotherapy of Cancer 14, no. 3 (2026). https://doi.org/10.1136/jitc-2025-012460.

MLA (9th ed.) Citation

CI, Lin, et al. "Liver-directed AAV-IL-10 Therapy Enhances CD8+ T Cell-mediated Immunity Against Hepatocellular Carcinoma." Journal for Immunotherapy of Cancer, vol. 14, no. 3, 2026, https://doi.org/10.1136/jitc-2025-012460.